Are you sure you want to log out?
You can always login again from the home screen

Thank You

Thank you for your feedback

Invasive Fungal Infections

Case 1 by Dr. Neil Stone

Invasive Fungal Infections

Case 2 by Dr. Joost Wauters

Invasive Fungal Infections

Case 3 by Dr. Ali Omrani

Invasive Fungal Infections

Case 4 by Dr. Reem Almaghrabi

COVID-19

A case of COVID-19 in the ICU presented by Prof. George Dimopoulos

COVID-19

Treatment and associated fungal Co-infection risk presented by Prof. Martin Heonigl

COVID-19

A case of fever, dyspnea, malaise and cough presented by Prof. Stefano Aliberti

Invasive Fungal Infections

ICU Corridor Part 1
Case 1: A case of IFI in a major abdominal surgery patient in ICU.
Case 2: A case of IFI in septic shock patient in ICU.

Invasive Fungal Infections

ICU Corridor Part 2
Case 3: A case of IFI in an ARDS patient in ICU.
Case 4: A case of IFI in COVID-19 patient in ICU.

Invasive Fungal Infections

ICU Corridor Part 3
Case 5: A case of IFI in diabetic & T-Cell lymphoblastic patient in ICU.
Case 6: A case of IFI in HIV patient in ICU.

Invasive Fungal Infections

ICU Corridor Part 4
Case 7: A case of IFI in an uncontrolled diabetic patient in ICU.
Case 8: A case of IFI in an influenza patient in ICU.

Liver Diseases

test video

HIV Academy

Case 2: The case of Nasser

HIV Academy

Case 3: The case of Leila

HIV Academy

Case 4: The case of Omar

HIV Academy

Case 5: The case of Latifah

HIV Academy

Case 6: The case of Sarah

HIV Academy

Case 1: The case of Abdullah

HIV

WebHIVE 2023: Webinars of HIV education

HIV

HIV Vision - Bulletin Series (Issue 1)

COVID-19

Incubation period of SARS-CoV-2 variants helps determine isolation period in COVID-19 : Study

HIV

Closing notes

HIV

Oral & Cutaneous Manifestations in PLWHIV

HIV

Immunization of people living with HIV and people

HIV

Retention in HIV care

HIV

Primary care management in PLWHIV

HIV

Mental health disorders in HIV

HIV

Day 2 Introduction

HIV

Linkage To Care

HIV

HIV Testing and diagnosis

HIV

Acute & Recent Hiv Infection

HIV

Hiv Epidemiology & Screening

HIV

Welcome & Program Introduction

HIV

Current HIV management guidelines

HIV

Metabolic changes in patients living with HIV: disentangling data

HIV

Day 1 - Session 1 - Panel Discussion

HIV

Long term treatment success in patients living with HIV

HIV

Clinical Case Discussion (1)

WebHIVE 2023: Webinars of HIV education

HIV Academy is an educational non-promotional program organized by Gilead Sciences Middle East that was started in 2017 to the present date. This year we are happy to announce the Academy will be covering HIV clinical cases that will equip HIV healthcare providers in the Middle East with the required knowledge, skills, and core competencies required to provide an up-todate evidence-based approach to the management of people living with HIV for better health outcomes and long term treatment success.

HIV Academy 2023

Gilead HIV Academy 2023 Middle East annual event

WebHIVe II: Long Term Outcomes

Educational webinar on HIV management focusing on long term outcomes of Patients Living with HIV. The webinar includes a patient experience via a patient /HCP interview (actor portrayal) from diagnosis to management to follow up over 10 years period of time

WebHIVe I

An educational webinar on HIV management focusing on redefining treatment goals based on new principles of maximal and durable viral load suppression, control inflammation, incorporate PROs and reducing HIV related comorbidities

HIV Academy 2022

Gilead HIV Academy 2022 Middle East annual event

HIV Academy 2020

Online HIV Academy to discuss recent updates of HIV management.

HIV Academy 2021

HIV Academy is an annual educational event organized by Gilead Middle East.

HIV Academy 2019

watch videos from the HIV Academy that took place on 20 April 2019 at the Crowne Plaza Hotel, Jeddah, Saudi Arabia.

HIV

Bulletin

HIV Vision - Bulletin Series (Issue 1)

HIV

Webcast

Pivotal Clinical Trials for B/F/TAF in virologically suppressed patients

Dr. Jameela Al-Salman

HIV

Webcast

Registration Clinical Trials for B/F/TAF in treatment naive patients

Dr. Jameela Al-Salman

HIV

Webcast

HIV and ageing

Professor Jacque Mokhbat

HIV

Event

Long Term Outcomes

Prof. Jürgen Rockstroh

HIV

Event

Introduction and Clinical Case 1

Prof. Jürgen Rockstroh

HIV

Event

Clinical Case 2 : Switch in virologically suppressed patients

Dr. Jameela Al-Salman

HIV

Event

Discussion and Conclusions

HIV

Event

Welcome and introduction

Dr. Mohammad alhazmi

HIV

Event

Principles of Antiretroviral Therapy: Should we redefine treatment goals

Professor Andrew Ustianowski

HIV

Event

Clinical Case 1

Dr. Jehad Abdallah

HIV

Event

Clinical Case 2

Dr. Alaa Alali

HIV

Event

Meeting summary and conclusions

HIV

Event

Welcome & Program Introduction

Gilead Team

HIV

Event

Hiv Epidemiology & Screening

Dr. Ali Elgalib

HIV

Event

Acute & Recent Hiv Infection

Dr Ghassan Wali

HIV

Event

HIV Testing and diagnosis

Maha Al Mozaini

HIV

Event

Linkage To Care

Dr. Ali Elgalib

HIV

Event

Day 2 Introduction

Gilead Team

HIV

Event

Mental health disorders in HIV

Mas Chaponda

Liver Diseases

Webcast

HBV Clinical Management - Clinical Cases

PROF. JÖRG PETERSEN

Liver Diseases

Webcast

HBV Management in Special Populations

KIMBERLY A. BROWN, MD, FAST, FAASLD, AGAF

Liver Diseases

Webcast

Viral Hepatitis 2020 Updates: AASLD and EASL Perspectives

PROF. NANCY REAU

Liver Diseases

Webcast

HCC Updates

MASSIMO COLOMBO, MD

Liver Diseases

Webcast

Liver Fibrosis: Facts & Challenges

PROF. DR. MED. FRANK TACKE

Liver Diseases

Webcast

HBV Management Evolving & Risks Monitoring

PROF. HENRY LIK YUEN CHAN

Invasive Fungal Infections

Webcast

13- Closing

Dr. Tariq Al Musawi

Invasive Fungal Infections

Webcast

12- Acute Infections in Immunocompromised Host

Dr. Tariq Al Musawi

Invasive Fungal Infections

Webcast

11- Peritonitis

Dr. Tariq Al Musawi

Invasive Fungal Infections

Webcast

10- Septic Arthritis

Dr. Tariq Al Musawi

Invasive Fungal Infections

Webcast

09- Pneumonia Presenting as ARDS (COVID-19)

Dr. Tariq Al Musawi

Invasive Fungal Infections

Webcast

08- Abscesses all together

Dr. Tariq Al Musawi

Invasive Fungal Infections

Webcast

07- Necrotizing fasciitis

Dr. Tariq Al Musawi

Invasive Fungal Infections

Webcast

06- Acute meningitis and encephalitis

Dr. Tariq Al Musawi

Invasive Fungal Infections

Webcast

05- Sepsis and Septic shock

Dr. Tariq Al Musawi

Invasive Fungal Infections

Webcast

04- Source control

Dr. Tariq Al Musawi

Invasive Fungal Infections

Webcast

03- Antimicrobials

Dr. Tariq Al Musawi

Invasive Fungal Infections

Webcast

02- Microbiology as simple as it can be

Dr. Tariq Al Musawi

Invasive Fungal Infections

Webcast

01- Welcome and introduction to RIDES

Dr. Tariq Al Musawi

COVID-19

Medshorts

Burden of new SARS-CoV-2 variants in India

COVID-19

Medshorts

Aggravating factors of post covid secondary fungal infections

COVID-19

Medshorts

Pulmonary Immunothrombosis leading to hypoxia in COVID-19

COVID-19

Medshorts

Statins linked to lower mortality in Covid-19

COVID-19

Medshorts

Administration of COVID-19 vaccines in immunocompromised patients

COVID-19

Medshorts

Symptom clusters in COVID-19: A potential clinical prediction tool from the COVID Symptom Study app

COVID-19

Medshorts

Fully vaccinated individuals may shed infectious COVID-19 virus

COVID-19

Medshorts

Covid-19 protection by pre-existing HCoV antibodies

COVID-19

Medshorts

Challenges in diagnosis and treatment of autonomic complications of COVID-19

COVID-19

Medshorts

COVID-19 - A seasonal low - temperature infection?

COVID-19

Medshorts

Delta variant B.1.617.2 is resistant to antibody neuralization

COVID-19

Medshorts

Antiviral drugs for the future

COVID-19

Medshorts

Fresh concerns and unanswered questions about new Omicron variant

COVID-19

Medshorts

Keeping pace with ever-evolving COVID-19 pneumonia

COVID-19

Medshorts

COVID19 Antivirals : Remdesivir to be active against Omicron variant

COVID-19

Medshorts

Is SARS-CoV2 Omicron variant more transmissible?

COVID-19

Medshorts

Health implications of the genetic drift in the genome of SARS COV-2

COVID-19

Medshorts

Importance of antivirals in curtailing the pandemic

COVID-19

Medshorts

Antiviral therapies and SARS-CoV2-host cell surface interactions

COVID-19

Medshorts

SARS-CoV2 variants: Transmissibility, resistance to host immunity and molecular diagnosis

Back to top